NeoPath AutoPap Primary Screener Use Would Reduce Labor Costs 25%
This article was originally published in The Gray Sheet
Executive Summary
Use of NeoPath's AutoPap automated primary Pap smear screener would be able to cut laboratory labor costs by 25% and allow for a 33% increase in productivity, NeoPath President and CEO Alan Nelson told analysts during a May 8 teleconference.